Why Need to Watch: The Estee Lauder Companies Inc. (NYSE:EL), Ericsson (NASDAQ:ERIC), Express Scripts Holding Company (NASDAQ:ESRX), Bristol-Myers Squibb Company (NYSE:BMY),

On 25 February, The Estee Lauder Companies Inc. (NYSE:EL) announced that it has acquired By Kilian, the Paris-based prestige fragrance brand that embodies timeless sophistication and modern luxury. Terms of the deal were not disclosed.

The Estee Lauder Companies Inc. (NYSE:EL) belongs to Consumer Goods sector. Its net profit margin is 10.70% and weekly performance is 0.50%. On last trading day company shares ended up at $91.79. The Estee Lauder Companies Inc. (NYSE:EL) distance from 50-day simple moving average (SMA50) is 5.73%.

Ericsson (NASDAQ:ERIC) has inked a five-year network enhancement contract with Telenor Group. The contract covers the design and implementation of 4G/LTE networks, along with the transformation of 2G and 3G networks in Thailand, Myanmar and Bangladesh.

Ericsson (NASDAQ:ERIC) belongs to Technology sector. Its net profit margin is 5.50% and weekly performance is -0.33%. On last trading day company shares ended up at $9.20. Ericsson (NASDAQ:ERIC) distance from 50-day simple moving average (SMA50) is 2.67%.

Express Scripts Holding Company (NASDAQ:ESRX) announced that it has entered into an accelerated share repurchase (ASR) agreement with Morgan Stanley & Co. LLC. Under the terms of the ASR agreement the Company will receive an aggregate initial delivery of approximately 32.1 million shares of the Company’s common stock in exchange for a prepayment of $2.8 billion.

Express Scripts Holding Company (NASDAQ:ESRX) shares moved up 2.35% in last trading session and ended the day at $71.33. ESRX Gross Margin is 8.50% and its return on assets is 4.70%. Express Scripts Holding Company (NASDAQ:ESRX) quarterly performance is -17.22%.

On 26 February, Bristol-Myers Squibb Company (NYSE:BMY) announced that the Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Opdivo (nivolumab) for two new indications – adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) after prior chemotherapy, and adults with advanced renal cell carcinoma (RCC) after prior therapy. Both indications are supported by Phase 3 studies in which Opdivodemonstrated a survival benefit versus a standard of care.

On 26 February, Bristol-Myers Squibb Company (NYSE:BMY) shares moved down -1.24% and was closed at $62.25. BMY EPS growth in last 5 year was -12.30%. Bristol-Myers Squibb Company (NYSE:BMY) year to date (YTD) performance is -9.51%.

Lumber Liquidators Holdings, Inc. (NYSE:LL) is set to issue its Q415 quarterly earnings data on Monday, February 29th. Analysts expect the company to announce earnings of ($0.20) per share and revenue of $252.04 million for the quarter.

Lumber Liquidators Holdings, Inc. (NYSE:LL) shares fell -1.16% in last trading session and ended the day at $11.11. LL Gross Margin is 32.60% and its return on assets is -4.00%. Lumber Liquidators Holdings, Inc. (NYSE:LL) quarterly performance is -26.52%.

Leave a Reply

Your email address will not be published. Required fields are marked *